Reuters: Health
Swiss drugmaker Novartis reported rising first-quarter sales and profit that beat analyst expectations and confirmed its 2020 targets as the coronavirus pandemic prompted patients to stock up on their prescriptions in advance.
Novartis posts first-quarter sales, profit beat as COVID-19 spurs prescriptions
Novartis posts first-quarter sales, profit beat as COVID-19 spurs prescriptions
Reuters: Health
Swiss drugmaker Novartis reported rising first-quarter sales and profit that beat analyst expectations and confirmed its 2020 targets as the coronavirus pandemic prompted patients to stock up on their prescriptions in advance.
Reuters: Health
Swiss drugmaker Novartis reported rising first-quarter sales and profit that beat analyst expectations and confirmed its 2020 targets as the coronavirus pandemic prompted patients to stock up on their prescriptions in advance.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment